Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their effectiveness has plateaued due to therapeutic resistance that renders tumor-infiltrating lymphocytes, or TILs, ineffective.
Report: Healthcare Needs to Diversify Workforce to Get Rid of Racial Inequalities
Racial and ethnic inequities in healthcare are found in every state in the U.S. despite the passage of legislation intended to improve health outcomes for